Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
European Cardiology
|
March 18, 2020
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
Christopher N Floyd
Clinical Medicine (London, England)
|
February 3, 2016
Hypertension - state of the art 2015
Christopher N Floyd
JRSM Cardiovascular Disease
|
November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuary
Christopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology
|
July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis
Christopher N Floyd, Albert Ferro
Pharmacology & Therapeutics
|
September 3, 2013
Mechanisms of aspirin resistance
Christopher N Floyd, Albert Ferro
Prostaglandins & Other Lipid Mediators
|
April 15, 2015
Antiplatelet drug resistance: Molecular insights and clinical implications
Christopher N Floyd, Albert Ferro
Current Opinion in Cardiology
|
May 14, 2020
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?
Christopher N Floyd, Anthony S Wierzbicki
Plos One
|
July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis
Christopher N Floyd, Agnesa Mustafa, Albert Ferro
Clinical Pharmacokinetics
|
May 10, 2012
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications
Christopher N Floyd, Gabriella Passacquale, Albert Ferro
British Journal of Clinical Pharmacology
|
March 19, 2015
Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis
Christopher A Rajkumar, Christopher N Floyd, Albert Ferro
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
European Cardiology
|
March 18, 2020
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
Christopher N Floyd
Clinical Medicine (London, England)
|
February 3, 2016
Hypertension - state of the art 2015
Christopher N Floyd
JRSM Cardiovascular Disease
|
November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuary
Christopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology
|
July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis
Christopher N Floyd, Albert Ferro
Pharmacology & Therapeutics
|
September 3, 2013
Mechanisms of aspirin resistance
Christopher N Floyd, Albert Ferro
Prostaglandins & Other Lipid Mediators
|
April 15, 2015
Antiplatelet drug resistance: Molecular insights and clinical implications
Christopher N Floyd, Albert Ferro
Current Opinion in Cardiology
|
May 14, 2020
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?
Christopher N Floyd, Anthony S Wierzbicki
Plos One
|
July 3, 2014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis
Christopher N Floyd, Agnesa Mustafa, Albert Ferro
Clinical Pharmacokinetics
|
May 10, 2012
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications
Christopher N Floyd, Gabriella Passacquale, Albert Ferro
British Journal of Clinical Pharmacology
|
March 19, 2015
Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis
Christopher A Rajkumar, Christopher N Floyd, Albert Ferro
Page
of 3